drugset / Trial / NCT05189535
"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"
RandomizedParallel-groupSingle-blindPrevention
Summary
The aim of this study is to evaluate the effect of pentoxifylline 400 mg twice daily administration on the prevention of paclitaxel-Induced peripheral neuropathy in breast cancer patients.
Timeline
- Start
- 2021-10-03
- Primary completion
- 2023-09-18
- Completion
- 2023-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pentoxifylline | Small molecule | 400 mg | Oral |
| Background | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |